SCHEMBL24140171

SCHEMBL24140171

COc1cc(/C=C/C(=O)OCC2OC(O)C(O)C(O)C2O)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.61
▸ EPHX2 P34913 1/20 0.56
▸ MET P08581 7/20 0.55
▸ CA12 O43570 5/20 0.55
▸ CA9 Q16790 5/20 0.55
▸ CA4 P22748 3/20 0.55
▸ CA6 P23280 3/20 0.55
▸ CA5A P35218 3/20 0.55
▸ CA7 P43166 3/20 0.55
▸ CA14 Q9ULX7 3/20 0.55
▸ CA5B Q9Y2D0 3/20 0.55
▸ CYP19A1 P11511 1/20 0.55
▸ PRKCA P17252 1/20 0.55
▸ TTR P02766 1/20 0.53
▸ HTR7 P34969 1/20 0.53
▸ CYP2D6 P10635 3/20 0.53
▸ CA1 P00915 3/20 0.53
▸ CA2 P00918 3/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ TSHR P16473 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18060061 0.99 MAOB (0.62) MAOBEPHX2METCA12CA9
SCHEMBL31689164 0.99 MAOB (0.62) MAOBEPHX2METCA12CA9
SCHEMBL17510046 0.99 MAOB (0.62) MAOBEPHX2METCA12CA9
SCHEMBL3366430 0.88 MAOB (0.60) MAOBEPHX2METCA12CA9
SCHEMBL28390903 0.88 PRKCA (0.68) CYP19A1PRKCATTRHSD17B10ALOX5
SCHEMBL6854015 0.84 MAOB (0.62) MAOBEPHX2METCA12CA9
SCHEMBL17938787 0.82 PTPN1 (0.58) EPHX2CA12CA9PRKCACA1
SCHEMBL29531074 0.82 LDHA (0.72) MAOBEPHX2CA12CA9CYP19A1
SCHEMBL27632141 0.82 LDHA (0.72) MAOBEPHX2CA12CA9CYP19A1
SCHEMBL12336324 0.81 TOP2A (0.55) MAOBCA12CA9CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210403498-A1 PHYTOCHEMICAL-FRUCTOOLIGOSACCHARIDE CONJUGATE, METHOD FOR PRODUCING SAME, AND USE THEREOF EVERGREEN BIO CO., LTD. (KR) 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403498-A1 PHYTOCHEMICAL-FRUCTOOLIGOSACCHARIDE CONJUGATE, METHOD FOR PRODUCING SAME, AND USE THEREOF SI, MLN, VIP MAOB 1214/4885EPHX2 1230/4885MET 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback